Showing results for "Life on the Edge" in Biological Sciences

Life is the most extraordinary phenomenon in the known universe; but how does it work? Even in this age of cloning and synthetic biology, the remarkable truth remains: nobody has ever made anything living entirely out of dead material. Life remains the only way to make life. Are we missing a vital ingredient in its creation? Like Richard Dawkins' The Selfish Gene, which provided a new perspective on how evolution works, Life on the Edge alters our understanding of life's dynamics.

Australopithecines, dinosaurs, trilobites - such fossils conjure up images of lost worlds filled with vanished organisms. But in the full history of life, ancient animals, even the trilobites, form only the half-billion-year tip of a nearly four-billion-year iceberg. Andrew Knoll explores the deep history of life from its origins on a young planet to the incredible Cambrian explosion, presenting a compelling new explanation for the emergence of biological novelty.

'Profound, lyrical, and fascinating, Life’s Edge will give you a newfound appreciation for life itself. It is the work of a master science writer at the height of his skills.' – Ed Yong, author of An Immense World We all assume we know what life is, but the more scientists learn about the...

Green belts are part of the landscape and psyche of post-war Britain, but have led to conflicts at every level of society - between conservationists and developers, town and country, politicians and people, nimbys and the forces of progress. Growing up on 'the last road in London' on an estate at the edge of the woods, John Grindrod had a childhood that mirrored these tensions. His family, too, seemed caught between two worlds: his wheelchair-bound mother and soft hearted father had moved from the inner city and had trouble adjusting.  

Summary The first source describes the resignation of all seven independent directors from 23andMe's board due to disagreements with CEO Anne Wojcicki regarding the company's strategic direction. These disagreements stemmed from Wojcicki's proposal to take the company private, which the board rejected due to a lack of a premium offer to shareholders. The second source discusses the potential future of 23andMe's genetic data as the company faces financial challenges and the possibility of going out of business. While the company emphasizes its commitment to privacy and its policy of anonymizing...